Shares of Geron Co. (NASDAQ:GERN – Get Rating) have received an average recommendation of “Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have issued a buy recommendation on the […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Equities analysts expect Epizyme, Inc. (NASDAQ:EPZM – Get Rating) to announce earnings per share (EPS) of ($0.35) for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Epizyme’s earnings, with the highest EPS estimate coming in at ($0.31) and the lowest estimate coming in at ($0.40). Epizyme posted earnings […]
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) major shareholder Growth N. V. Biotech acquired 150,000 shares of the business’s stock in a transaction on Monday, April 18th. The shares were purchased at an average cost of $3.29 per share, for a total transaction of $493,500.00. Following the completion of the acquisition, the insider now […]
Wall Street analysts expect Merus (NASDAQ:MRUS – Get Rating) to report ($0.66) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Merus’ earnings, with the lowest EPS estimate coming in at ($0.73) and the highest estimate coming in at ($0.56). Merus reported earnings of ($0.28) per […]